Results 1 to 10 of about 144,610 (311)
Neoadjuvant therapy for breast cancer [PDF]
Journal of Surgical Oncology, 2010 AbstractThe past few decades have seen an increase in both the role and the complexity of neoadjuvant therapy for breast cancer. Neoadjuvant therapy was initially described as systemic chemotherapy for inflammatory or locally advanced breast cancer but now entails a combination of chemotherapy, endocrine therapy, and targeted therapy.
Stephen V Liu +2 more
exaly +3 more sources
Expert consensus on neoadjuvant treatment of breast cancer in China (2021 edition) [PDF]
Zhongguo aizheng zazhi, 2022 Neoadjuvant therapy has become one of the standard treatments in early breast cancer. In 2019, China breast cancer neoadjuvant therapy expert group discussed and expounded the purpose, indication, evaluation criteria, surgical operation principles and ...
Expert group of expert consensus on neoadjuvant treatment of breast cancer in China ( edition)
doaj +1 more source
Neoadjuvant therapy in patients with locally advanced colon cancer [PDF]
Waike lilun yu shijian, 2022 It is still unclear about neoadjuvant therapy in patients with locally advanced colon cancer (LACC). This review summarized neoadjuvant chemotherapy, neoadjuvant chemotherapy combined with targeted therapy and combined radio-chemotherapy for the patients
XU Zifeng, ZONG Yaping, LU Aiguo
doaj +1 more source
Neoadjuvant Therapy for Locally Advanced Esophageal Cancers
Frontiers in Oncology, 2022 Esophageal carcinoma is one of the most aggressive malignant diseases. At present, neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy are regarded as the standard modalities for the treatments of locally advanced esophageal cancers based on ...
Runkai Huang +8 more
doaj +1 more source
Neoadjuvant therapy for gallbladder cancer: current status and challenge [PDF]
Waike lilun yu shijian, 2023 Gallbladder cancer is one of highly malignant digestive system tumors with insidious symptoms, rapid progression, and poor prognosis. Although radical resective surgery is the only possible curative way for gallbladder cancer, most patients have lost the
XING Ying, CHENG Shi
doaj +1 more source
Frontiers in Oncology, 2023 BackgroundThe emergence of immune checkpoint inhibitors (ICIs) has brought about a paradigm shift in the treatment landscape of non-small cell lung cancer (NSCLC).
Qin Wang +7 more
doaj +1 more source
Neoadjuvant therapy for melanoma: rationale for neoadjuvant therapy and pivotal clinical trials [PDF]
Therapeutic Advances in Medical Oncology, 2022 The treatment of malignant melanoma has drastically changed over the past decade with the advent of immune checkpoint blockade, targeted therapy with BRAF/MEK inhibition, and other novel therapies such as oncolytic virus intralesional therapy. Despite improvements in patient response rates and survival with these new treatments, there exists a large ...
Russell G. Witt +2 more
openaire +3 more sources
Neoadjuvant therapy with Disitamab vedotin in treating muscle-invasive bladder cancer: A case report
Heliyon, 2023 Purpose: Platinum-based regimens are regarded as the preferred alternative for neoadjuvant chemotherapy for muscle-invasive bladder cancer (MIBC) patients. However, some patients cannot tolerate platinum-based regimens. We report an MIBC case with severe
Haijun Huang +5 more
doaj +1 more source
Indian Journal of Pathology and Microbiology, 2023 Background: The efficacy of neoadjuvant therapy for rectal cancer has not been assessed. Objective: To evaluate proportional changes in peripheral blood immune cells in rectal cancer patients after neoadjuvant therapy and assess the relationship between ...
Liu Maoxi, Liu Haiyi
doaj +1 more source
Frontiers in Oncology, 2022 IntroductionNeoadjuvant trastuzumab plus chemotherapy may affect programmed death-ligand 1 (PD-L1) expression and tumor-infiltrating lymphocytes (TILs) in HER2-positive breast cancer.
Mao Shang +9 more
doaj +1 more source